期刊文献+

宫颈癌筛查方法及其进展 被引量:11

Methods and progress of cervical cancer screening
下载PDF
导出
摘要 子宫颈癌起源于子宫颈上皮内瘤变,筛查发现子宫颈上皮内瘤变并积极治疗是预防子宫颈癌的有效措施。目前常用的宫颈癌筛查方法包括细胞学检查及人乳头瘤病毒(HPV)检测。细胞学检查及HPV检测均有新的筛查方法及进展。细胞学检查除了传统的巴氏细胞学检测及目前常用的液基细胞学检测,现部分医院开始采用细胞DNA倍性分析、P16/Ki67双染等方法辅助诊断。而HPV检测除了常规的HPV DNA检测,现较热门的是HPV E6/E7 mRNA检测,HPV E6/E7 m RNA检测可补充细胞学检查及HPV DNA检测的不足。现综述目前所采用的宫颈癌筛查方法及进展,为临床上宫颈癌筛查方法选择提供参考。 Cervical cancer originated from cervical intraepithelial neoplasia,and screening and active treatment are effective measures to prevent cervical cancer.The most commonly used methods for cervical cancer screening include cytology and human papillomavirus testing.There are new screening methods and progress in cytology and HPV testing.In addition to the traditional Papanicolaou cytology test and the commonly used liquid-based cytology test,DNA ploidy analysis and P16/Ki67 double staining have been used to assist the diagnosis in some hospitals.In addition to conventional HPV DNA testing,HPV E6/E7 mRNA testing is now more popular,which can supplement cytology and HPV DNA detection deficiencies.This article reviews the current methods and progress of cervical cancer screening for clinical cervical cancer screening methods to provide reference.
作者 郑楚丽 宋硕 谭晓瑜(综述) 符爱珍(审校) ZHENG Chu-li;SONG Shuo;TAN Xiao-yu;FU Ai-zhen(Guangdong Medical University,Zhanjiang 524000,Guangdong,CHINA)
机构地区 广东医科大学
出处 《海南医学》 CAS 2021年第5期662-665,共4页 Hainan Medical Journal
关键词 子宫颈 宫颈上皮内瘤变 乳头状瘤病毒科 巴氏细胞学检查 液基细胞学检查 HPV E6/E7mRNA 宫颈癌筛查 Cervix uteri Cervical intraepithelial neoplasia Papillomaviridae Pap cytology Liquid-based cytology HPV E6/E7 m RNA Cervical cancer screening
  • 相关文献

参考文献4

二级参考文献24

  • 1Bosch FX,Lorincz A,Munoz N,et al.The causal relation between human papillomavirus and cervical cancer.J Clin Pathol,2002,55(4):244-265.
  • 2Molano M,Posso H,Weiderpass E,et al.Prevalence and determinants of HPV infection among Colombian women with normal cytology.Br J Cancer,2002,87(3):324-333.
  • 3Pham TH,Nguyen TH,Herrero R,et al.Human papillomavirus infection among women in South and North Vietnam.Int J Cancer,2003,104(2):213-220.
  • 4Thomas DB,Qin Q,Kuypers J,et al.Human papillomaviruses and cervical cancer in Bangkok,Ⅱ:risk factors for in situ and invasive squamous cell cervical carcinomas.Am J Epidemiol,2001,153(8):732-739.
  • 5Cuzik J.HPV testing in cervical screening.JAMA,2000,283(1):108-109.
  • 6Schiffiman M,Herrero R,Hidesheim A,et al.HPV DNA testing in cervical cancer screening:results from woman in a high-risk Province of Costa Rica.JAMA,2000,283(1):87-93.
  • 7Ledger W J,Jeremias J,Wit kin SS,et al.Testing for highrisk human papilloma virus types will become a standard of clinical care.Am J Obstet Gynecol,2000,182(4):860-865.
  • 8Wright TC,Denny L,Kuhul,et al.HPV DNA testing of selfcollected vaginal samples compared with cytologic screening to detect cervical cancer.JAMA,2000,283(1):81-86
  • 9Belinson J,Qiao YL,Pretorius R,et al.Prevalence of cervical cancer and feasibility of screening in rural China:a pilot study for the Shaanxi province cervical cancer screening study.Int J Gynecol Cancer,1999,9 (5):411-417.
  • 10Petry KU,Menton S,Menton M,et al.Inclusion of HPV testing in routine cervical cancer screening for women above 29years in Germany:results for 8466 patients.Br J Cancer,2003,88(10):1570-1577.

共引文献107

同被引文献127

引证文献11

二级引证文献37

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部